|
1
|
Tan DX, Zheng X, Kong J, Manchester LC,
Hardeland R, Kim SJ, Xu X and Reiter RJ: Fundamental issues related
to the origin of melatonin and melatonin isomers during evolution:
Relation to their biological functions. Int J Mol Sci.
15:15858–15890. 2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Emet M, Ozcan H, Ozel L, Yayla M, Halici Z
and Hacimuftuoglu A: A review of melatonin, its receptors and
drugs. Eurasian J Med. 48:135–141. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Slominski AT, Zmijewski MA, Semak I, Kim
TK, Janjetovic Z, Slominski RM and Zmijewski JW: Melatonin,
mitochondria, and the skin. Cell Mol Life Sci. 74:3913–3925.
2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Liu J, Clough SJ, Hutchinson AJ,
Adamah-Biassi EB, Popovska-Gorevski M and Dubocovich ML: MT1 and
MT2 melatonin receptors: A therapeutic perspective. Annu Rev
Pharmacol Toxicol. 56:361–383. 2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Reiter RJ, Mayo JC, Tan DX, Sainz RM,
Alatorre-Jimenez M and Qin L: Melatonin as an antioxidant: Under
promises but over delivers. J Pineal Res. 61:253–278.
2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Armstrong SM: Melatonin and circadian
control in mammals. Experientia. 45:932–938. 1989.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Hardeland R: Melatonin and
inflammation-Story of a double-edged blade. J Pineal Res.
65(e12525)2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Tordjman S, Chokron S, Delorme R, Charrier
A, Bellissant E, Jaafari N and Fougerou C: Melatonin: Pharmacology,
functions and therapeutic benefits. Curr Neuropharmacol.
15:434–443. 2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Xia Y, Chen S, Zeng S, Zhao Y, Zhu C, Deng
B, Zhu G, Yin Y, Wang W, Hardeland R and Ren W: Melatonin in
macrophage biology: Current understanding and future perspectives.
J Pineal Res. 66(e12547)2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Hardeland R: Aging, melatonin, and the
Pro- and anti-inflammatory networks. Int J Mol Sci.
20(1223)2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kopustinskiene DM and Bernatoniene J:
Molecular mechanisms of Melatonin-mediated cell protection and
signaling in health and disease. Pharmaceutics.
13(129)2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Nikolaev G, Robeva R and Konakchieva R:
Membrane melatonin receptors activated cell signaling in physiology
and disease. Int J Mol Sci. 23(471)2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Tan DX, Reiter RJ, Manchester LC, Yan MT,
El-Sawi M, Sainz RM, Mayo JC, Kohen R, Allegra M and Hardeland R:
Chemical and physical properties and potential mechanisms:
Melatonin as a broad spectrum antioxidant and free radical
scavenger. Curr Top Med Chem. 2:181–197. 2002.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Okamoto HH, Cecon E, Nureki O, Rivara S
and Jockers R: Melatonin receptor structure and signaling. J Pineal
Res. 76(e12952)2024.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Klosen P: Thirty-seven years of MT1 and
MT2 melatonin receptor localization in the brain: Past and future
challenges. J Pineal Res. 76(e12955)2024.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Afsar B, Elsurer Afsar R, Sag AA, Kanbay
A, Korkmaz H, Cipolla-Neto J, Covic A, Ortiz A and Kanbay M: Sweet
dreams: Therapeutic insights, targeting imaging and physiologic
evidence linking sleep, melatonin and diabetic nephropathy. Clin
Kidney J. 13:522–530. 2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Ekmekcioglu C: Melatonin receptors in
humans: Biological role and clinical relevance. Biomed
Pharmacother. 60:97–108. 2006.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Cagampang FR and Bruce KD: The role of the
circadian clock system in nutrition and metabolism. Br J Nutr.
108:381–392. 2012.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Sanchez-Hidalgo M, de la Lastra CA,
Carrascosa-Salmoral MP, Naranjo MC, Gomez-Corvera A, Caballero B
and Guerrero JM: Age-related changes in melatonin synthesis in rat
extrapineal tissues. Exp Gerontol. 44:328–334. 2009.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Thul PJ and Lindskog C: The human protein
atlas: A spatial map of the human proteome. Protein Sci.
27:233–244. 2018.PubMed/NCBI View
Article : Google Scholar
|
|
21
|
Karlsson M, Zhang C, Mear L, Zhong W,
Digre A, Katona B, Sjöstedt E, Butler L, Odeberg J, Dusart P, et
al: A single-cell type transcriptomics map of human tissues. Sci
Adv. 7(eabh2169)2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Acuna-Castroviejo D, Rahim I,
Acuna-Fernandez C, Fernández-Ortiz M, Solera-Marín J, Sayed RKA,
Díaz-Casado ME, Rusanova I, López LC and Escames G: Melatonin,
clock genes and mitochondria in sepsis. Cell Mol Life Sci.
74:3965–3987. 2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Konturek SJ, Konturek PC, Brzozowska I,
Pawlik M, Sliwowski Z, Cześnikiewicz-Guzik M, Kwiecień S,
Brzozowski T, Bubenik GA and Pawlik WW: Localization and biological
activities of melatonin in intact and diseased gastrointestinal
tract (GIT). J Physiol Pharmacol. 58:381–405. 2007.PubMed/NCBI
|
|
24
|
Fagerberg L, Hallstrom BM, Oksvold P,
Kampf C, Djureinovic D, Odeberg J, Habuka M, Tahmasebpoor S,
Danielsson A, Edlund K, et al: Analysis of the human
tissue-specific expression by genome-wide integration of
transcriptomics and Antibody-based proteomics. Mol Cell Proteomics.
13:397–406. 2014.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Huang YS, Lo CH, Tsai PH, Hou YC, Chang
YT, Guo CY, Hsieh HY, Lu KC, Shih HM and Wu CC: Downregulation of
AANAT by c-Fos in tubular epithelial cells with membranous
nephropathy. Biochem Biophys Res Commun. 584:32–38. 2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Huang YS, Lu KC, Chao HW, Chen A, Chao TK,
Guo CY, Hsieh HY, Shih HM, Sytwu HK and Wu CC: The MTNR1A mRNA is
stabilized by the cytoplasmic hnRNPL in renal tubular cells. J Cell
Physiol. 236:2023–2035. 2021.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Gazon H, Barbeau B, Mesnard JM and
Peloponese JM Jr: Hijacking of the AP-1 Signaling pathway during
development of ATL. Front Microbiol. 8(2686)2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Hardeland R, Tan DX and Reiter RJ:
Kynuramines, metabolites of melatonin and other indoles: The
resurrection of an almost forgotten class of biogenic amines. J
Pineal Res. 47:109–126. 2009.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Ma X, Idle JR, Krausz KW and Gonzalez FJ:
Metabolism of melatonin by human cytochromes p450. Drug Metab
Dispos. 33:489–494. 2005.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Tang KS, Ho CY, Hsu CN and Tain YL:
Melatonin and Kidney Health: From Fetal Stage to Later Life. Int J
Mol Sci. 24(8105)2023.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Cecon E, Oishi A and Jockers R: Melatonin
receptors: Molecular pharmacology and signalling in the context of
system bias. Br J Pharmacol. 175:3263–3280. 2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Dubocovich ML, Delagrange P, Krause DN,
Sugden D, Cardinali DP and Olcese J: International union of basic
and clinical pharmacology. LXXV. Nomenclature, classification, and
pharmacology of G protein-coupled melatonin receptors. Pharmacol
Rev. 62:343–380. 2010.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Liu L, Labani N, Cecon E and Jockers R:
Melatonin target proteins: Too many or not enough? Front Endocrinol
(Lausanne). 10(791)2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Smirnov AN: Nuclear melatonin receptors.
Biochemistry (Mosc). 66:19–26. 2001.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Slominski RM, Reiter RJ,
Schlabritz-Loutsevitch N, Ostrom RS and Slominski AT: Melatonin
membrane receptors in peripheral tissues: Distribution and
functions. Mol Cell Endocrinol. 351:152–166. 2012.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Takahashi JS: Transcriptional architecture
of the mammalian circadian clock. Nat Rev Genet. 18:164–179.
2017.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Jockers R, Delagrange P, Dubocovich ML,
Markus RP, Renault N, Tosini G, Cecon E and Zlotos DP: Update on
melatonin receptors: IUPHAR Review 20. Br J Pharmacol.
173:2702–2725. 2016.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Hardeland R, Cardinali DP, Srinivasan V,
Spence DW, Brown GM and Pandi-Perumal SR: Melatonin-a pleiotropic,
orchestrating regulator molecule. Prog Neurobiol. 93:350–384.
2011.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Reppert SM, Weaver DR and Godson C:
Melatonin receptors step into the light: Cloning and classification
of subtypes. Trends Pharmacol Sci. 17:100–102. 1996.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Tao L and Zhu Y: Melatonin regulates
CRE-dependent gene transcription underlying osteoblast
proliferation by activating Src and PKA in parallel. Am J Transl
Res. 10:86–100. 2018.PubMed/NCBI
|
|
41
|
Alexander SP, Davenport AP, Kelly E,
Marrion N, Peters JA, Benson HE, Faccenda E, Pawson AJ, Sharman JL,
Southan C, et al: The Concise Guide to PHARMACOLOGY 2015/16: G
protein-coupled receptors. Br J Pharmacol. 172:5744–5869.
2015.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Brydon L, Roka F, Petit L, de Coppet P,
Tissot M, Barrett P, Morgan PJ, Nanoff C, Strosberg AD and Jockers
Rl: Dual signaling of human Mel1a melatonin receptors via G(i2),
G(i3), and G(q/11) proteins. Mol Endocrinol. 13:2025–2038.
1999.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Tosini G, Owino S, Guillaume JL and
Jockers R: Understanding melatonin receptor pharmacology: Latest
insights from mouse models, and their relevance to human disease.
Bioessays. 36:778–787. 2014.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Tocharus C, Puriboriboon Y, Junmanee T,
Tocharus J, Ekthuwapranee K and Govitrapong P: Melatonin enhances
adult rat hippocampal progenitor cell proliferation via ERK
signaling pathway through melatonin receptor. Neuroscience.
275:314–321. 2014.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Xia AY, Zhu H, Zhao ZJ, Liu HY, Wang PH,
Ji LD and Xu J: Molecular mechanisms of the melatonin receptor
pathway linking circadian rhythm to type 2 diabetes mellitus.
Nutrients. 15(1406)2023.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Li DY, Smith DG, Hardeland R, Yang MY, Xu
HL, Zhang L, Yin HD and Zhu Q: Melatonin receptor genes in
vertebrates. Int J Mol Sci. 14:11208–11223. 2013.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Reppert SM: Melatonin receptors: Molecular
biology of a new family of G protein-coupled receptors. J Biol
Rhythms. 12:528–531. 1997.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Inoue T and Koike H: High-resolution
low-temperature scanning electron microscopy for observing
intracellular structures of quick frozen biological specimens. J
Microsc. 156:137–147. 1989.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Huang YS, Lu KC, Chao TK, Chen JS, Chen A,
Guo CY, Hsieh HY, Shih HM, Sytwu HK and Wu CC: Role of melatonin
receptor 1A and pituitary homeobox-1 coexpression in protecting
tubular epithelial cells in membranous nephropathy. J Pineal Res.
65(e12482)2018.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Couser WG: Primary membranous nephropathy.
Clin J Am Soc Nephrol. 12:983–997. 2017.PubMed/NCBI View Article : Google Scholar
|
|
51
|
AlYousef A, AlSahow A, AlHelal B, Alqallaf
A, Abdallah E, Abdellatif M, Nawar H and Elmahalawy R:
Glomerulonephritis histopathological pattern change. BMC Nephrol.
21(186)2020.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Hill SM, Cheng C, Yuan L, Mao L, Jockers
R, Dauchy B, Frasch T and Blask DE: Declining melatonin levels and
MT1 receptor expression in aging rats is associated with enhanced
mammary tumor growth and decreased sensitivity to melatonin. Breast
Cancer Res Treat. 127:91–98. 2011.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Adi N, Mash DC, Ali Y, Singer C, Shehadeh
L and Papapetropoulos S: Melatonin MT1 and MT2 receptor expression
in Parkinson's disease. Med Sci Monit. 16:BR61–ER67.
2010.PubMed/NCBI
|
|
54
|
Huang YS, Hsieh HY, Shih HM, Sytwu HK and
Wu CC: Urinary Xist is a potential biomarker for membranous
nephropathy. Biochem Biophys Res Commun. 452:415–421.
2014.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Wu CC, Lu KC, Lin YF, Chen JS, Huang CF,
Chen CC, Lin SH, Chu P and Sytwu HK: Pathogenic role of effector
cells and immunoglobulins in cationic bovine serum albumin-induced
membranous nephropathy. J Clin Immunol. 32:138–149. 2012.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Wu CC, Lu KC, Lin GJ, Hsieh HY, Chu P, Lin
SH and Sytwu HK: Melatonin enhances endogenous heme oxygenase-1 and
represses immune responses to ameliorate experimental murine
membranous nephropathy. J Pineal Res. 52:460–469. 2012.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Wu CC, Chen JS, Huang CF, Chen CC, Lu KC,
Chu P, Sytwu HK and Lin YF: Approaching biomarkers of membranous
nephropathy from a murine model to human disease. J Biomed
Biotechnol. 2011(581928)2011.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Wu CC, Chen JS, Lin SH, Chen A, Sytwu HK
and Lin YF: Experimental model of membranous nephropathy in mice:
Sequence of histological and biochemical events. Lab Anim.
42:350–359. 2008.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Wu CC, Chen JS, Chen SJ, Lin SH, Chen A,
Chang LC, Sytwu HK and Lin YF: Kinetics of adaptive immunity to
cationic bovine serum albumin-induced membranous nephropathy.
Kidney Int. 72:831–840. 2007.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Koyanagi S, Hamdan AM, Horiguchi M,
Kusunose N, Okamoto A, Matsunaga N and Ohdo S: cAMP-response
element (CRE)-mediated transcription by activating transcription
factor-4 (ATF4) is essential for circadian expression of the
Period2 gene. J Biol Chem. 286:32416–32423. 2011.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Stuparevic I, Novacic A, Rahmouni AR,
Fernandez A, Lamb N and Primig M: Regulation of the conserved
3'-5'exoribonuclease EXOSC10/Rrp6 during cell division, development
and cancer. Biol Rev Camb Philos Soc. 96:1092–1113. 2021.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Schmid M and Jensen TH: The exosome: A
multipurpose RNA-decay machine. Trends Biochem Sci. 33:501–510.
2008.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Johnston JD, Klosen P, Barrett P and
Hazlerigg DG: Regulation of MT melatonin receptor expression in the
foetal rat pituitary. J Neuroendocrinol. 18:50–56. 2006.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Johnston JD, Schuster C, Barrett P and
Hazlerigg DG: Regulation of the ovine MT1 melatonin receptor
promoter: Interaction between multiple pituitary transcription
factors at different phases of development. Mol Cell Endocrinol.
268:59–66. 2007.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Kim M, de la Pena JB, Cheong JH and Kim
HJ: Neurobiological functions of the period circadian clock 2 gene,
Per2. Biomol Ther (Seoul). 26:358–367. 2018.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Huang YS, Lu KC, Chang YT, Ka SM, Guo CY,
Hsieh HY, Shih HM, Sytwu HK and Wu CC: Melatonin alleviates
Albumin-induced tubular cell injury by activating Clock-controlled
nuclear enriched abundant transcript 1-mediated proliferation. ACS
Pharmacol Transl Sci. 7:3607–3617. 2024.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Alexopoulos E, Papagianni A and
Papadimitriou M: Is membranous nephropathy only a glomerular
disease? Ren Fail. 20:1–6. 1998.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Remuzzi G, Ruggenenti P and Benigni A:
Understanding the nature of renal disease progression. Kidney Int.
51:2–15. 1997.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Albert FW and Kruglyak L: The role of
regulatory variation in complex traits and disease. Nat Rev Genet.
16:197–212. 2015.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Daher G, Santos-Bezerra DP, Cavaleiro AM,
Pelaes TS, Admoni SN, Perez RV, Machado CG, do Amaral FG,
Cipolla-Neto J and Correa-Giannella ML: Rs4862705 in the melatonin
receptor 1A gene is associated with renal function decline in type
1 diabetes individuals. Front Endocrinol (Lausanne).
15(1331012)2024.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Loos F, Maduro C, Loda A, Lehmann J,
Kremers GJ, Ten Berge D, Grootegoed JA and Gribnau J: Xist and tsix
transcription dynamics is regulated by the X-to-autosome ratio and
semistable transcriptional states. Mol Cell Biol. 36:2656–2667.
2016.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Lee JT, Davidow LS and Warshawsky D: Tsix,
a gene antisense to Xist at the X-inactivation centre. Nat Genet.
21:400–404. 1999.PubMed/NCBI View
Article : Google Scholar
|
|
73
|
Bisikirska B, Labella R, Cuesta-Dominguez
A, Luo N, De Angelis J, Mosialou I, Lin CS, Beck D, Lata S, Shyu
PT, et al: Melatonin receptor 1A variants as genetic cause of
idiopathic osteoporosis. Sci Transl Med.
16(eadj0085)2024.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Watt SM: The long and winding road:
Homeostatic and disordered haematopoietic microenvironmental
niches: A narrative review. Biomater Transl. 3:31–54.
2022.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Zhai H, Ni L and Wu X: The roles of heme
oxygenase-1 in renal disease. Front Nephrol.
3(1156346)2023.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Lee SC, Han SH, Li JJ, Lee SH, Jung DS,
Kwak SJ, Kim SH, Kim DK, Yoo TH, Kim JH, et al: Induction of heme
oxygenase-1 protects against podocyte apoptosis under diabetic
conditions. Kidney Int. 76:838–848. 2009.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Li HB, Mo YS, Zhang XZ, Zhou Q, Liang XD,
Song JN, Hou LN, Wu JN, Guo Y, Feng DD, et al: Heme oxygenase-1
inhibits renal tubular epithelial cell pyroptosis by regulating
mitochondrial function through PINK1. Exp Ther Med.
25(213)2023.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Rublevskaya I and Maines MD: Interaction
of Fe-protoporphyrin IX and heme analogues with purified
recombinant heme oxygenase-2, the constitutive isozyme of the brain
and testes. J Biol Chem. 269:26390–26395. 1994.PubMed/NCBI
|
|
79
|
Stow LR and Gumz ML: The circadian clock
in the kidney. J Am Soc Nephrol. 22:598–604. 2011.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Sasaki YT, Ideue T, Sano M, Mituyama T and
Hirose T: MENepsilon/beta noncoding RNAs are essential for
structural integrity of nuclear paraspeckles. Proc Natl Acad Sci
USA. 106:2525–2530. 2009.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Sun X and Kaufman PD: Ki-67: More than a
proliferation marker. Chromosoma. 127:175–186. 2018.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Rahman A, Hasan AU and Kobori H: Melatonin
in chronic kidney disease: A promising chronotherapy targeting the
intrarenal renin-angiotensin system. Hypertens Res. 42:920–923.
2019.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Koch BC, van der Putten K, Van Someren EJ,
Wielders JP, Ter Wee PM, Nagtegaal JE and Gaillard CA: Impairment
of endogenous melatonin rhythm is related to the degree of chronic
kidney disease (CREAM study). Nephrol Dial Transplant. 25:513–519.
2010.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Ishigaki S, Ohashi N, Isobe S, Tsuji N,
Iwakura T, Ono M, Sakao Y, Tsuji T, Kato A, Miyajima H and Yasuda
H: Impaired endogenous nighttime melatonin secretion relates to
intrarenal renin-angiotensin system activation and renal damage in
patients with chronic kidney disease. Clin Exp Nephrol. 20:878–884.
2016.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Satari M, Bahmani F, Reiner Z, Soleimani
A, Aghadavod E, Kheiripour N and Asemi Z: Metabolic and
Anti-inflammatory response to melatonin administration in patients
with diabetic nephropathy. Iran J Kidney Dis. 1:22–30.
2021.PubMed/NCBI
|
|
86
|
Hoxha E, Reinhard L and Stahl RAK:
Membranous nephropathy: New pathogenic mechanisms and their
clinical implications. Nat Rev Nephrol. 18:466–478. 2022.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Makhammajanov Z, Gaipov A, Myngbay A,
Bukasov R, Aljofan M and Kanbay M: Tubular toxicity of proteinuria
and the progression of chronic kidney disease. Nephrol Dial
Transplant. 39:589–599. 2024.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Hanset N, Esteve E, Plaisier E, Johanet C,
Michel PA, Boffa JJ, Fievet P, Mesnard L, Morelle J, Ronco P and
Dahan K: Rituximab in patients with phospholipase A2
Receptor-associated membranous nephropathy and severe CKD. Kidney
Int Rep. 5:331–338. 2020.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Trujillo H, Alonso M and Praga M: New ways
of understanding membranous nephropathy. Nephron. 144:261–271.
2020.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Rojas-Rivera JE, Ortiz A and Fervenza FC:
Novel treatments paradigms: Membranous nephropathy. Kidney Int Rep.
8:419–431. 2023.PubMed/NCBI View Article : Google Scholar
|
